Emmessar Biotech & Nutrition Ltd

AI
Emmessar Biotech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Emmessar Biotech & Nutrition Ltd

₹
- close price
ebnl.org BSE: 524768
About

Emmessar Biotech & Nutrition Ltd is a standalone healthcare-products and property-leasing company. It manufactures /trades a small VedaCeuticals portfolio and earns rent from sub-leasing its MIDC Taloja industrial land; FY26 filings report Healthcare and Rent on Leasehold Land as the only operating segments.[1]

Key Points

Business Overview:[1]
EBNL is a global healthcare company
that manufactures and markets health
care & nutritional products. It fuses
various concepts & principles (both
ancient & modern) from Biophysics, Biochemistry, Biotechnology and
the Indian system of medicine AYUSH
(Ayurveda + Yoga + Unani + Siddha
+ Homeopathy) to create products.
This integration resulted in technology
called VedaCeuticals which forms
the foundation of all products of
EBNL

Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE %
  • ROE %
  • Face Value ₹
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF
Upcoming result date: 31 October 2026

Profit & Loss

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Figures in Rs. Crores

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Figures in Rs. Crores

Net Cash Flow
Free Cash Flow
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit

Ratios
Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Insights

In beta
Mar 2016 Mar 2017 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export of Goods (FOB Value)
Rs Lakhs ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Lease Income (Rent on Leasehold Land)
Rs Lakhs ・Standalone data
Manufactured Goods Revenue
Rs Lakhs ・Standalone data
Traded Goods Revenue
Rs Lakhs ・Standalone data
Number of Permanent Employees
count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53% 59.53%
0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19% 0.19%
40.28% 40.26% 40.27% 40.27% 40.28% 40.27% 40.28% 40.28% 40.27% 40.26% 40.26% 40.28%
No. of Shareholders 6,8447,1466,9006,9367,1867,1807,1737,3507,2447,1727,1367,144

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports